Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Self-administered acupressure for constipation in adult psychiatric inpatients

Official title: Effectiveness of Self-Administered Acupressure Intervention in Managing Constipation of Adult Psychiatric In-Patient

Run by Hong Kong Metropolitan University · NCT07039448 · Data updated 2026-11-12

This project tests whether adult psychiatric inpatients can reduce constipation symptoms by using self-administered acupressure.

More Constipation trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment154 (estimated)
SponsorHong Kong Metropolitan University
Academic / other
Locations1 site (Tuenmen, New Territories)
StatusRecruiting
StartedJuly 2025
Main results expectedNovember 2026
Study endsMay 2027
Registry record updatedJune 26, 2025
Trial IDNCT07039448 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Hong Kong Chinese adults (18+) who are psychiatric inpatients, mentally stable, meet Rome III criteria for constipation, and can learn and perform self‑acupressure.

Probably not a fit

Patients with anatomical GI disorders, metabolic or endocrine causes of constipation, prior acupressure training, upper-limb disabilities, planned surgery during the study, or pregnancy are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adult psychiatric inpatients in Hong Kong who meet Rome III criteria for constipation will be taught specific self‑acupressure techniques and compared with a sham‑acupressure group. The intervention involves brief training in acupressure points and a scheduled self‑care practice period while outcomes are tracked over follow-up. Eligibility requires mental stability and the physical ability to perform acupressure, excluding those with major gastrointestinal, metabolic, or upper‑limb problems. The trial is run at Castle Peak Hospital in collaboration with Hong Kong Metropolitan University and the Hospital Authority.

Why it matters

Potential benefit: If successful, this could provide a low-cost, low-risk self-care method to reduce constipation and improve comfort for psychiatric inpatients.

How similar studies have gone: Previous trials of acupressure or acupuncture for general constipation have produced mixed but sometimes positive results, while randomized evidence specifically in psychiatric inpatient populations is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Hong Kong Chinese residents, aged 18 or above
2. Meet the diagnostic criteria of Rome III for constipation
3. Mentally stable and competent for self-care and learning acupressure, as recommended by their attending psychiatrists and
4. Able to understand the questionnaire and follow instructions for training will be eligible to participate in this study

Exclusion Criteria:

1. Anatomical and physiological disorders of gastrointestinal tract such as malrotation, fistula and colonic neuropathies
2. Metabolic and endocrine diseases
3. Lead poisoning and vitamin D intoxication
4. Previous training in acupressure
5. Physical disability involved the upper limbs
6. Planned surgery undergoing during study period and pregnancy.

Where it's running

  • Castle Peak Hospital
    Tuenmen, New Territories, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.